For Healthcare Professionals: Ovarian Cancer

We offer a comprehensive, multidisciplinary team approach to screening, counseling, and treating women with ovarian cancer. Improved surgical techniques and refinements in postoperative care are largely responsible for recent improvements in outcomes for women with this malignancy. For staging early cancers that appear to be confined to the ovary, our surgeons are often able to use small-incision minimally invasive surgery via standard laparoscopy or the robotically assisted da Vinci® Surgical System – and have found that these approaches are as effective and accurate as staging during open surgery.

Refering a Patient

Call 866-280-0449
Mon–Fri, 8:30 AM–5:30 PM, ET

Find an Expert | See Clinical Trials | Request a Pathology Consult

More Science. Less Fear.
It’s Time to Change How the World Treats Cancer.

Learn how we’re making what was impossible yesterday possible today.

Prediction Tools

Our ovarian cancer nomogram is an online tool that can be used to help predict the chance that a patient will not survive five years after primary surgery for epithelial ovarian cancer.

Pictured: Dennis Chi
Ovarian Cancer Information for Your Patients

The Memorial Sloan Kettering approach to diagnosis and treatment of ovarian cancer in patient-friendly language.

E-Publications for Medical Professionals

Stay up-to-date on Memorial Sloan Kettering advances in your areas of interest.

Subscribe to OncoNotes »

Pictured: Mario Leitao, Jr.
Robotic Surgery for Gynecologic Cancers

Co-Director of Robotic Surgery Mario Leitao, Jr., describes the emerging role and clear benefits of the robotic platform for operating on gynecologic cancers.

Hyperthermic Intraperitoneal Chemotherapy for Ovarian Cancer

Gynecologic oncologist Oliver Zivanovic describes the use of heated intraperitoneal chemotherapy to treat ovarian cancer.

Pictured: Dennis Chi
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

Gynecologic oncologist Dennis Chi describes a clinical trial evaluating secondary cytoreduction with and without HIPEC for various malignancies.

Pictured: Mario Leitao, Jr.
Robotic Surgery
Ovarian Cancer HIPEC
Pictured: Dennis Chi
HIPEC for Recurrent Disease